When prevention works, it is a cost-effective element of any long-term cancer control strategy. Little is known, however, about the actual effects and causal links between preventive policies on cancer incidence, and mortality. Evidence linking prevention to verified results is scarce, and often unclear regarding which policies and programs work, and to what degree.

How strong is the case for cancer prevention? How should prevention be incorporated into national cancer plans? And ultimately, what is the role of prevention in evidenced-based health policy decision-making?

The debate, started at the European Cancer Forum, continues with a new webinar in the series Issues in Cancer Care – The Early Bird Debate.

One issue, two speakers, two opinions, register now for the next webinar “Cancer preventions: What’s worth the effort?” on 24 November 2020, from 8:30 AM and hear from:

Dr. Thomas Hofmarcher

Research Manager, The Swedish Institute for Health Economics

Nikolai Pushkarev

Policy Coordinator Food systems & NCD Prevention, European Public Health Alliance

Moderated by:

Duane Schulthess

Managing Director, Vital Transformation